RMOC work programme

Title Submitted Action Committee Committee meeting Further details Expected guidance
Stopping medication 23/04/2018 RMOC work programme topic London
prescribing of insulin in frail and elderly who are being managed at home 17/04/2018 RMOC work programme topic Midlands and East
Learning Disabilities Mortality Review (LeDeR) 10/04/2018 RMOC work programme topic North
Evidence for the use of heparinised saline for maintaining patency of intravascular catheters 03/04/2018 RMOC work programme topic London 04/07/2018
The RMOC will review the evidence and issue a recommendation for the efficacy of heparinised saline versus normal saline for maintaining the patency of intravascular catheters
15/08/2018
Sodium Oxybate 14/03/2018 RMOC work programme topic Midlands and East 08/08/2018
NHS England has a commissioning policy for sodium oxybate for narcolepsy in children however there is no similar policy for adults. The RMOC will discuss the issues that arise when children transition to adult services, with the aim to make a recommendation that addresses these issues.
19/09/2018
Evidence based recommendation for use of Botox 13/03/2018 RMOC work programme topic South 27/09/2018
The RMOC will identify a list of indications botulinum toxin A is used in, and assess the level of evidence underpinning these indications. The intention is to provide evidence-based recommendations on use of botulinum toxin A in off-label indications, to support a consistent approach to treatment.
08/11/2018
Shared care agreements 09/03/2018 RMOC work programme topic South 03/05/2018
RMOC South discussed the recently published guidance from NHS England (Responsibility for prescribing between Primary & Secondary/Tertiary Care). Discussion focused on how RMOCs can achieve their expectations as set out in section 6 of this guidance. A survey was sent across the South region to identify the types of issues that organisations have with shared care. This will be presented at the next RMOC South meeting.
Regional availability of rarely used and emergency medicines 25/01/2018 RMOC work programme topic London 01/03/2018
The RMOC system has now issued guidance on this issue which is available here: https://sps-dev.makeandship.com/articles/regional-medicines-optimisation-committee-antidotes-and-rums-position-statement/. Further work in 2018 will seek to implement this guidance in collaboration with regional procurement pharmacists and other groups.
22/05/2018
Rationalisation of Insulin Products 16/01/2018 RMOC work programme topic Midlands and East 18/04/2018
The RMOC system has now issued guidance to formulary committees. Area Prescribing Committees on issues pertaining to safety considerations when adopting any insulin preparation onto a local formulary. https://sps-dev.makeandship.com/articles/insulin-preparations-rmoc-recommendations-of-safety-considerations-for-formulary-decision-making/
22/06/2018
STOMP (Stopping over­medication of people with a learning disability) 16/01/2018 RMOC work programme topic North 28/06/2018
The STOMP programme was developed as part of the national response to the Winterbourne View Hospital report. It aims to ensure that people with learning difficulties, or autism, or both, are not over-medicated. The North RMOC will lead this work as part of the polypharmacy work stream, on behalf of all RMOCs. It will work with STOMP colleagues to provide a resource pack on the SPS website which can used locally to inform local policies. The RMOC will also work with STOMP colleagues to facilitate the development of prescribing guidance and prescribing indicators that can be utilised locally.
09/08/2018
National standardisation for medicines agreements over the interface (shared care) 16/01/2018 RMOC work programme topic South 03/05/2018
This is a large piece of work which needs an agreed mechanism of delivery to ensure it is addressed appropriately across England. This is currently being discussed within the RMOC governance structure. An update will be provided once a decision is reached.
Shared Care Protocols & Traffic Light Drugs lists 16/01/2018 RMOC work programme topic South
Antidepressant prescribing in primary/secondary care 16/01/2018 RMOC work programme topic South 03/05/2018
RMOC South is leading on this as part of the Polypharmacy workstream on behalf of all RMOCs. The RMOC will work with clinical specialists to produce a resource pack to publish on the SPS website. It intends to identify signposting opportunities to help health care professionals and practitioners.
Compassionate care and free of charge medicines guidance 15/01/2018 RMOC work programme topic South 30/01/2018
The Medicines Optimisation Clinical Reference Group has drafted guidance to reduce variation in how organisations and APCs respond to Free of Charge schemes. The guidance is intended to improve consistency of approach taken, particularly in terms of patient safety and regulatory governance. Following consultation with RMOC members, this will be published as an RMOC Recommendation and Resource.
03/08/2018
Shared care new EL: primary and secondary care responsibilities 15/01/2018 RMOC work programme topic South 30/01/2018
RMOC discussed draft guidance and fed back comments to NHS England.
Low clinical value medicines 15/01/2018 RMOC work programme topic South 03/05/2018
Low clinical value medicines: liothyronine. This topic focuses on prescribing of liothyronine. RMOC South is working with endocrinology clinical specialists to produce guidance on prescribing of liothyronine.
27/09/2018
Medication Safety tools in primary care 15/01/2018 RMOC work programme topic South 30/01/2018
RMOC South will work with the AHSNs to produce guidance on the following areas: 1. Introduction to PINCER 2. Cost-effectiveness review of available tools 3. Best practice guidance 4. Checklist for self-assessment when using medication safety tools 5. Signposting to support implementation
08/11/2018
Homely remedies 15/01/2018 RMOC work programme topic Midlands and East 08/08/2018
The RMOC will discuss issues pertaining to use of "homely remedies" in care homes and other residential or secure institutions. "Homely remedies" are over-the-counter or non-prescription medicines used to treat minor ailments. The RMOC aims to issue a recommendation relating to this topic.
19/09/2018
Medicines use in Care Homes 15/01/2018 RMOC work programme topic Midlands and East
Medicines use in Care Homes 15/01/2018 RMOC work programme topic London
Polypharmacy 15/01/2018 RMOC work programme topic South 03/05/2018
This is an on-going topic for discussion at RMOCs as part of the Medicines Value Programme. Polypharmacy will continue to be discussed on the South RMOC agenda, with a focus on deprescribing and polypharmacy in care homes. Work will be joined up with organisations such as AHSNs.
Polypharmacy 15/01/2018 RMOC work programme topic London 04/07/2018
This is an on-going topic for discussion at RMOCs as part of the Medicines Value Programme. The London RMOC has established a polypharmacy subgroup, jointly chaired by Professors Nina Barnett and Emma Baker. The subgroup has undertaken an analysis of the existing patient pathway that precipitates polypharmacy, both longitudinally and cross-sectionally; it has also undertaken a forces analysis of the factors causing inappropriate polypharmacy. The subgroup will focus on how medicines optimisation review can be used effectively to avoid inappropriate polypharmacy.
Polypharmacy 15/01/2018 RMOC work programme topic Midlands and East
Polypharmacy 15/01/2018 RMOC work programme topic North 28/06/2018
This is an on-going topic for discussion at RMOCs as part of the Medicines Value Programme. The North RMOC has identified STOMP as an important programme of work to focus on.
Anti-microbial resistance 15/01/2018 RMOC work programme topic South 03/05/2018
This is an on-going topic for discussion at RMOCs as part of the Medicines Value Programme. The South RMOC will identify ways in which it can support the AMR stewardship agenda through: o Reducing inappropriate antibiotic prescribing in primary care; implementing new NICE common infections guidance. o Asking acute Trusts what strategies are in place to promote an increase in IV to PO antibiotic administration. o Enabling development of a local whole health economy approach & use of networks to drive AMR improvement including infection prevention and control.
Anti-microbial resistance 15/01/2018 RMOC work programme topic London 04/07/2018
This is an on-going topic for discussion at RMOCs as part of the Medicines Value Programme. The London RMOC has established a subgroup with a remit to focus its attention on three areas: (1) sharing best practice on UTI prevention, diagnosis and treatment in the elderly; (2) use of antibiotics in the urgent care setting; (3) working with STPs to map current antimicrobial stewardship activity.
Anti-microbial resistance 15/01/2018 RMOC work programme topic Midlands and East
Anti-microbial resistance 15/01/2018 RMOC work programme topic North 28/06/2018
This is an on-going topic for discussion at RMOCs as part of the Medicines Value Programme. The RMOC has discussed the data and information presented relating to antimicrobial resistance and agreed to follow up various actions around these data with CCGs and Trusts not meeting targets within the north region.
Biosimilar medicines 15/01/2018 RMOC work programme topic South 03/05/2018
This is an on-going topic for discussion at RMOCs as part of the Medicines Value Programme. The South RMOC has established a subgroup to provide recommendations on uptake of Best Value Biological Medicines across the sector. The subgroup will report back at subsequent RMOC meetings.
Biosimilar medicines 15/01/2018 RMOC work programme topic London 04/07/2018
This is an on-going topic for discussion at RMOCs as part of the Medicines Value Programme. The London RMOC has established a subgroup which will report back at subsequent meetings.